Last reviewed · How we verify
OLIVE OIL
At a glance
| Generic name | OLIVE OIL |
|---|---|
| Drug class | Lipid Emulsion [EPC] |
| Phase | FDA-approved |
| First approval | 2013 |
Approved indications
- Minor skin irritation and itching relief
Common side effects
Key clinical trials
- Nutrition for Precision Health, Powered by the All of Us (NA)
- Nutritional Intervention for College Students With Depression (NA)
- Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome (NA)
- Effect of the Consumption of Cookies Enriched With Plant Proteins and of a Vitamin D Supplement on the Progression of Sarcopenia in the Elderly (NA)
- Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults (PHASE2)
- Structured Physical Activity Intervention in Patients With MASLD Receiving a Mediterranean Diet (NA)
- Clinical Efficacy of NST With Adjunctive Local Delivery of Ozonated Olive Versus Curcumin Gel in Stage II Grade B Periodontitis. (NA)
- Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OLIVE OIL CI brief — competitive landscape report
- OLIVE OIL updates RSS · CI watch RSS